A Boston-based biotech company called Pieris Pharmaceuticals announced it’s been selected to receive a $14.2 million euro ($17 million USD) grant from the Bavarian Ministry…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.